PROCEPT BioRobotics (PRCT) awards RSUs and stock options to EVP and CLO
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp executive Nouri Alaleh reported equity compensation awards on August 13, 2026. He received 22,965 shares of Common Stock in the form of restricted stock units (RSUs), each representing one share, increasing his direct Common Stock holdings to 128,034 shares after the grant.
Alaleh was also granted a Stock Option for 31,773 shares of Common Stock at an exercise price of $21.95 per share, expiring on August 12, 2036, bringing his directly held stock options from this grant to 31,773. The RSUs vest 25% on August 13, 2027, with the remaining three-quarters vesting quarterly over 36 months, while 1/48th of the option shares vest monthly from August 13, 2026 over four years, in each case subject to continued service. Both awards are intended to represent 50% of the value of his expected 2027 grant, made in lieu of that portion of the future grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 22,965 shares
Net Buy
2 txns
Insider
Nouri Alaleh
Role
EVP, CLO, CORP. SEC.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 31,773 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 22,965 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 31,773 shares (Direct);
Common Stock — 128,034 shares (Direct)
Footnotes (2)
- F1. 1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
- F2. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
Key Figures
RSUs granted: 22,965 shares
Common Stock held after RSU grant: 128,034 shares
Stock options granted: 31,773 shares
+5 more
8 metrics
RSUs granted
22,965 shares
Restricted stock units granted to Nouri Alaleh on August 13, 2026
Common Stock held after RSU grant
128,034 shares
Direct Common Stock holdings of Nouri Alaleh following RSU acquisition
Stock options granted
31,773 shares
Stock Option (Right to Buy) granted on August 13, 2026
Stock option exercise price
$21.95 per share
Exercise price of the 31,773-share Stock Option grant
Stock option expiration
August 12, 2036
Expiration date of the Stock Option granted to Nouri Alaleh
Initial RSU cliff vesting
25% on August 13, 2027
First vesting tranche of the 22,965 RSUs, then quarterly over 36 months
Option vesting pace
1/48th monthly over 4 years
Vesting schedule for Stock Option from August 13, 2026
Portion of expected 2027 grant value
50%
Both awards represent 50% of the value of the expected 2027 grant
Key Terms
restricted stock units, vesting commencement date, Stock Option (Right to Buy), contingent right to receive one share, +1 more
5 terms
restricted stock units financial
"These securities are restricted stock units (RSUs). Each RSU represents a contingent right"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting commencement date financial
"1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
expiration date financial
"expiration_date: 2036-08-12"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What equity awards did PROCEPT BioRobotics (PRCT) EVP Nouri Alaleh receive on August 13, 2026?
On August 13, 2026, Nouri Alaleh received 22,965 RSUs and a Stock Option for 31,773 shares of PROCEPT BioRobotics Common Stock at an exercise price of $21.95 per share, all as part of his equity compensation.
How do the new RSUs granted to PROCEPT BioRobotics (PRCT) EVP Nouri Alaleh vest?
The 22,965 RSUs vest 25% on August 13, 2027, with the remaining three-quarters vesting in quarterly installments over 36 months, conditioned on Alaleh continuing as a service provider through each applicable vesting date.
What are the key terms of Nouri Alaleh’s new stock option from PROCEPT BioRobotics (PRCT)?
The stock option covers 31,773 shares of Common Stock at an exercise price of $21.95 per share and expires on August 12, 2036. 1/48th of the shares vest monthly from August 13, 2026 over four years, subject to continued employment or service.
How do these 2026 equity awards relate to Nouri Alaleh’s expected 2027 grant at PROCEPT BioRobotics (PRCT)?
Both the 22,965 RSUs and the 31,773-share stock option are intended to constitute 50% of the value of Alaleh’s expected 2027 grant, and they are granted in lieu of that portion of the future 2027 equity award.
Are Nouri Alaleh’s new PROCEPT BioRobotics (PRCT) equity awards dependent on continued employment?
Yes. Vesting of both the RSUs and the stock option requires Alaleh to continue as an employee or service provider through each scheduled vesting date, as specified in the award footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
